Literature DB >> 24900850

Minibody-indocyanine green based activatable optical imaging probes: the role of short polyethylene glycol linkers.

Rira Watanabe1, Kazuhide Sato1, Hirofumi Hanaoka1, Toshiko Harada1, Takahito Nakajima1, Insook Kim2, Chang H Paik3, Anna M Wu4, Peter L Choyke1, Hisataka Kobayashi1.   

Abstract

Minibodies show rapider blood clearance than IgGs due to smaller size that improves target-to-background ratio (TBR) in in vivo imaging. Additionally, the ability to activate an optical probe after binding to the target greatly improves the TBR. An optical imaging probe based on a minibody against prostate-specific membrane antigen (PSMA-MB) and conjugated with an activatable fluorophore, indocyanine green (ICG), was designed to fluoresce only after binding to cell-surface PSMA. To further reduce background signal, short polyethylene glycol (PEG) linkers were employed to improve the covalent bonding ratio of ICG. New PSMA-MBs conjugated with bifunctional ICG derivatives specifically visualized PSMA-positive tumor xenografts in mice bearing both PSMA-positive and -negative tumors within 6 h postinjection. The addition of short PEG linkers significantly improved TBRs; however, it did not significantly alter the biodistribution. Thus, minibody-ICG conjugates could be a good alternative to IgG-ICG in the optical cancer imaging for further clinical applications.

Entities:  

Keywords:  Molecular imaging; indocyanine green; minibody; near-infrared fluorescence; prostate cancer

Year:  2014        PMID: 24900850      PMCID: PMC4027604          DOI: 10.1021/ml400533y

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  22 in total

1.  Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms.

Authors:  T Yokota; D E Milenic; M Whitlow; J Schlom
Journal:  Cancer Res       Date:  1992-06-15       Impact factor: 12.701

2.  ImmunoPET using engineered antibody fragments: fluorine-18 labeled diabodies for same-day imaging.

Authors:  Tove Olafsen; Shannon J Sirk; Sebastian Olma; Clifton K-F Shen; Anna M Wu
Journal:  Tumour Biol       Date:  2012-03-06

3.  Glowing tumors make for better detection and resection.

Authors:  Michael Bouvet; Robert M Hoffman
Journal:  Sci Transl Med       Date:  2011-11-23       Impact factor: 17.956

4.  Targeted, activatable, in vivo fluorescence imaging of prostate-specific membrane antigen (PSMA) positive tumors using the quenched humanized J591 antibody-indocyanine green (ICG) conjugate.

Authors:  Takahito Nakajima; Makoto Mitsunaga; Neil H Bander; Warren D Heston; Peter L Choyke; Hisataka Kobayashi
Journal:  Bioconjug Chem       Date:  2011-07-27       Impact factor: 4.774

5.  Real-time whole-body imaging of an orthotopic metastatic prostate cancer model expressing red fluorescent protein.

Authors:  Meng Yang; Ping Jiang; Norio Yamamoto; Lingna Li; Jack Geller; A R Moossa; Robert M Hoffman
Journal:  Prostate       Date:  2005-03-01       Impact factor: 4.104

6.  Short PEG-linkers improve the performance of targeted, activatable monoclonal antibody-indocyanine green optical imaging probes.

Authors:  Kohei Sano; Takahito Nakajima; Kiminori Miyazaki; Yuya Ohuchi; Takashi Ikegami; Peter L Choyke; Hisataka Kobayashi
Journal:  Bioconjug Chem       Date:  2013-05-03       Impact factor: 4.774

Review 7.  Indocyanine green angiography in chorioretinal diseases: indications and interpretation: an evidence-based update.

Authors:  Paulo E Stanga; Jennifer I Lim; Peter Hamilton
Journal:  Ophthalmology       Date:  2003-01       Impact factor: 12.079

8.  Activatable fluorescent cys-diabody conjugated with indocyanine green derivative: consideration of fluorescent catabolite kinetics on molecular imaging.

Authors:  Kohei Sano; Takahito Nakajima; Towhid Ali; Derek W Bartlett; Anna M Wu; Insook Kim; Chang H Paik; Peter L Choyke; Hisataka Kobayashi
Journal:  J Biomed Opt       Date:  2013-10       Impact factor: 3.170

9.  Poly(ethylene glycol)-Prodrug Conjugates: Concept, Design, and Applications.

Authors:  Shashwat S Banerjee; Naval Aher; Rajesh Patil; Jayant Khandare
Journal:  J Drug Deliv       Date:  2012-05-07

10.  Marketed therapeutic antibodies compendium.

Authors:  Janice M Reichert
Journal:  MAbs       Date:  2012-04-26       Impact factor: 5.857

View more
  9 in total

1.  PSMA-targeted contrast agents for intraoperative imaging of prostate cancer.

Authors:  Kai Bao; Jeong Heon Lee; Homan Kang; G Kate Park; Georges El Fakhri; Hak Soo Choi
Journal:  Chem Commun (Camb)       Date:  2017-01-13       Impact factor: 6.222

2.  Vision 20/20: Molecular-guided surgical oncology based upon tumor metabolism or immunologic phenotype: Technological pathways for point of care imaging and intervention.

Authors:  Brian W Pogue; Keith D Paulsen; Kimberley S Samkoe; Jonathan T Elliott; Tayyaba Hasan; Theresa V Strong; Daniel R Draney; Joachim Feldwisch
Journal:  Med Phys       Date:  2016-06       Impact factor: 4.071

Review 3.  The therapeutic and diagnostic potential of the prostate specific membrane antigen/glutamate carboxypeptidase II (PSMA/GCPII) in cancer and neurological disease.

Authors:  James C Evans; Meenakshi Malhotra; John F Cryan; Caitriona M O'Driscoll
Journal:  Br J Pharmacol       Date:  2016-09-23       Impact factor: 8.739

Review 4.  Monoclonal antibody-based optical molecular imaging probes; considerations and caveats in chemistry, biology and pharmacology.

Authors:  Hisataka Kobayashi; Peter L Choyke; Mikako Ogawa
Journal:  Curr Opin Chem Biol       Date:  2016-06-06       Impact factor: 8.822

Review 5.  Leveraging Engineering of Indocyanine Green-Encapsulated Polymeric Nanocomposites for Biomedical Applications.

Authors:  Ya-Hui Han; Ranjith Kumar Kankala; Shi-Bin Wang; Ai-Zheng Chen
Journal:  Nanomaterials (Basel)       Date:  2018-05-24       Impact factor: 5.076

6.  Near-infrared-induced drug release from antibody-drug double conjugates exerts a cytotoxic photo-bystander effect.

Authors:  Kazuomi Takahashi; Hirotoshi Yasui; Shunichi Taki; Misae Shimizu; Chiaki Koike; Kentaro Taki; Hiroshi Yukawa; Yoshinobu Baba; Hisataka Kobayashi; Kazuhide Sato
Journal:  Bioeng Transl Med       Date:  2022-08-21

Review 7.  Antibody Fragment and Affibody ImmunoPET Imaging Agents: Radiolabelling Strategies and Applications.

Authors:  Ruisi Fu; Laurence Carroll; Gokhan Yahioglu; Eric O Aboagye; Philip W Miller
Journal:  ChemMedChem       Date:  2018-11-15       Impact factor: 3.466

8.  Spatiotemporal depletion of tumor-associated immune checkpoint PD-L1 with near-infrared photoimmunotherapy promotes antitumor immunity.

Authors:  Shunichi Taki; Kazuhide Sato; Kohei Matsuoka; Yuko Nishinaga; Kazuomi Takahashi; Hirotoshi Yasui; Chiaki Koike; Misae Shimizu; Mitsuo Sato
Journal:  J Immunother Cancer       Date:  2021-10       Impact factor: 12.469

9.  HER2 targeting near-infrared photoimmunotherapy for a CDDP-resistant small-cell lung cancer.

Authors:  Kazuomi Takahashi; Shunichi Taki; Hirotoshi Yasui; Yuko Nishinaga; Yoshitaka Isobe; Toshinori Matsui; Misae Shimizu; Chiaki Koike; Kazuhide Sato
Journal:  Cancer Med       Date:  2021-11-02       Impact factor: 4.452

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.